Total issued shares after the split (Class A plus Class B), less all Class B and the insider Class A (Yang/More Healthy and the officers/directors).
Data-service feed, fetched today. The number TradingView and most screeners show.
Your screener's float is right for ZCMD. Trade off 2.88M shares. What it does not show you is what is about to be added to it.
The float your screener shows is right, at 2.88M. 1 convertible note and 5 reverse splits can add another 161% of the float.
Reverse split history / serial dilution cycle. Four consolidations in 2026: 1:8 (Mar), 1:31 (Jun 8), 1:3 (Jun 29) and 1:2 (Oct 2).
Rapid share count growth. Split-adjusted shares outstanding went from about 20,759 at 2025-12-31 to about 4.23M.
Serial financing cadence. Three priced offerings in about 9 weeks (June 3, July 23, August 5) through the same agent.
From today's float to the ceiling
sharesWhere the shares come from
each subtotal is a rung on the ladder above
Not counted anywhere: ATM and shelf capacity. Convertible share counts use stated conversion prices.
See the full breakdown
Red flags, financing counterparties, the deal timeline, and every SEC filing — free with an account.
Sign in to continueThe facts
Market data as of Nov 22, 2026
Key dates
- Jan 21, 2027 · Six-month Rule 144 holding period ends for the CEO's 1.25M award Class A after the split (affiliate volume limits apply)
- Mar 24, 2027 · Univest's 8-month right of first refusal on future financings expires
- Feb 10, 2029 · Shareholder authority for further 2:1–31.25:1 consolidations expires